December 2022

BroadOak portfolio company PhenoVista Biosciences, a leading provider of both custom and off-the-shelf imaging-based assay services, received an investment from Fujifilm's Life Sciences Corporate Venture Capital Fund to accelerate development of new high-content screening assay services using differentiated iPSCs. The full press release is below. TOKYO, December...